What we do

Training

Opportunities for growth and learning

Young people entering the biotech arena, be it in R&D or business, have the opportunity to learn from the wealth of experience of renowned scientists and seasoned business professionals. Through our PREVENT seminars, symposiums and fellowships, we coordinate training and education in the combined disciplines of vaccine research and commercialization, opening for students, doors to the 'real world of vaccine research and development.

Our lineup of symposiums covers a wide variety of interests, from clinical research to economic analysis. Established to act as a catalyst for vaccine development, PREVENT provides a forum for discussion, knowledge building and links and connections between R&D and business development.

Further opportunities include PREVENT internships at three of the nation's pre-eminent research institutes, offering trainees a front-row seat to witness and learn how technology moves from the lab bench to the commercial arena.

people in lab As the PREVENT enterprise grows and strengthens, we will welcome accomplished and talented people to work with us, increasing the pool of highly qualified personnel in vaccine discovery and development within Canada.

Headquartered at the University of Saskatchewan, PREVENT operates within the highly sophisticated existing infrastructure of VIDO/Intervac. This 'home' enables our organization to minimize early-development costs and focus PREVENT funding on the implementation of Canada’s New Vaccine Pipeline strategy.



Did you know?
image of influenza virus

The three influenza viruses that affect humans are Influenzavirus A (humans, other mammals & birds), Influenzavirus B (humans & seals), and Influenzavirus C (humans & pigs). Influenzavirus A is responsible for most flu pandemics. The virus can be transmitted through airborne particles – coughs or sneezes – contaminated surfaces, or in the case of avian influenza, through infected bird droppings. The influenza virus can survive in sub-zero temperatures, but is easily killed with disinfectants and detergents.

BACKGROUNDER

Immunization:
Inoculation and Vaccination

Inoculation (also known as variolation) was introduced to the west by Lady Mary Wortley Montagu (1689-1762), who witnessed inoculation being
portrait of lady
practiced by physicians in Constantinople,[12] and was greatly impressed:[13] she had lost a brother to smallpox and bore facial scars from the disease herself. In 1718 she had the embassy surgeon inoculate her son, and in 1721, after returning to England, had her daughter inoculated[14]. In 1722 the Prince of Wales' daughters received inoculations[16].

The practice of inoculation slowly spread amongst the royal families of Europe, followed by general adoption amongst the rest of the population. Given the severe consequences of smallpox in Europe in the 18th century, many parents felt that the benefits outweighed the risks and so inoculated their children.[21] [22]